Akero Therapeutics Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Akero Therapeutics (AKRO) PT Raised to $75 at Jefferies
January 29, 2025 4:08 PM ESTJefferies analyst Michael Yee raised the price target on Akero Therapeutics (NASDAQ: AKRO) to $75.00 (from $50.00) while maintaining a Buy rating.
The analyst comments "We raise our PT to $75 based on $5-6B cap or $2-3B+ clear oppty in NASH based on strong F4... More



